submit to the journals

EAN Highlights

flipper_slider

Editor's Choice

Celia Oreja-Guevara (Vice Chair of Neurology and Head of Multiple Sclerosis Center, University Hospital San Carlos, and Professor of Neurology, University Complutense, Madrid, Spain) discusses the background and...

EAN Highlights Videos

K Ray Chaudhuri (Professor of Movement Disorders, Neuroscience Research and Development, King's College; Director, King’s Parkinson’s Centre, King’s College Hospital, London, UK) discusses the major unmet needs in the care of patients with advanced Parkinson's disease (PD) and at what stage to...
K Ray Chaudhuri (Professor of Movement Disorders, Neuroscience Research and Development, King's College; Director, King’s Parkinson’s Centre, King’s College Hospital, London, UK) considers the major societal burden of Parkinson's disease (PD) and what early symptoms doctors should be on the lookout...
Joaquim Ferreira (EAN Local Organising Committee Chair; Professor of Neurology and Clinical Pharmacology, Faculty of Medicine, University of Lisbon; Head of CNS - Campus Neurológico, Portugal) shared with us his personal highlights hosting EAN 2018 in Lisbon. Questions 1. As Chair of the EAN’s...
Peter Goadsby (Professor of Neurology, Headache Group, King’s College Hospital, London, UK) discusses erenumab for the prevention of migraine, including the rationale, findings and clinical implications of the LIBERTY study. Questions 1. Could you tell us a little about erenumab and its...
Aksel Siva (EAN Programme Committee; Professor of Neurology, Istanbul University, Cerrahpasa School of Medicine, Turkey) talks to us about various treatment considerations in multiple sclerosis (MS): induction, individualised therapy, optimal therapeutic window and when to switch therapies. Part 2...
Aksel Siva (EAN Programme Committee; Professor of Neurology, Istanbul University, Cerrahpasa School of Medicine, Turkey) talks to us about various treatment considerations in multiple sclerosis (MS): induction, individualised therapy, optimal therapeutic window and when to switch therapies. Part 1...
Pille Taba (EAN Programme Committee and Teaching Course Sub-committee; MDS-ES Representative; Professor of Neurology, Department of Neurology and Neurosurgery, University of Tartu, Estonia) tells us what she considers major challenges and important developments in Parkinson's disease. Questions...
David B Vodušek (EAN Communication Committee Chair, Professor of Neurology, Division of Neurology, University Medical Centre Ljubljana, Slovenia) discusses his role as chair of the EAN European Affairs Sub-committee and the importance of links between the EAN and partner organisations. Part 2 of 2...
David B Vodušek (EAN Communication Committee Chair, Professor of Neurology, Division of Neurology, University Medical Centre Ljubljana, Slovenia) discusses his role as chair of the EAN European Affairs Sub-committee and the importance of links between the EAN and partner organisations. Part 1 of 2...
Antonio Federico (EAN Scientific Committee Chair; Professor, Clinical Neurology and Neurometabolic Diseases, University of Siena, Italy) describes the impact increased migration has had on the pathophysiology of neurological conditions and the need to increase awareness of this amongst neurologists...
Antonio Federico (EAN Scientific Committee Chair; Professor, Clinical Neurology and Neurometabolic Diseases, University of Siena, Italy) discusses the unique challenges that rare neurological diseases bring and how the EAN have a Task Force focused on this important area. Questions 1. Could you...
Günther Deuschl (EAN President; Professor of Neurology, Department of Neurology, University Hospital Schleswig-Holstein, Kiel Campus, Germany) kindly took the time to discuss with us the burden of neurological diseases in Europe, including disparities across our continent, and how the EAN aims to...
Günther Deuschl (EAN President; Professor of Neurology, Department of Neurology, University Hospital Schleswig-Holstein, Kiel Campus, Germany) kindly took the time to discuss with us the burden of neurological diseases in Europe, including disparities across our continent, and how the EAN aims to...
Franz Fazekas (EAN President Elect; Professor of Neurology and Head, Department of Neurology, Medical University of Graz, Austria) kindly took the time to tell us about EAN's mission to support and cooperate with national neurological societies, as well as their endeavours to attract more...
Ivan Rektor (EAN Programme Committee; Professor of Neurology, Faculty of Medicine and Central European Institute of Technology [CEITEC], Neuroscience Centre, Masaryk University, Brno, Czech Republic) provides a fascinating update on his research examining large-scale brain network functional...